Literature DB >> 11179820

Alternative splicing of transcripts expressed by the Manduca sexta allatotropin (Mas-AT) gene is regulated in a tissue-specific manner.

F M Horodyski1, S R Bhatt, K Y Lee.   

Abstract

The Manduca allatotropin (Mas-AT) gene is expressed as at least three mRNA isoforms that differ from each other by alternative splicing. The location at which the alternative exons are included in the mature mRNAs occur within the open reading frame, so that three different propeptides are predicted as translation products. In the pharate adult insect, the major mRNA isoform expressed in the brain and frontal ganglion differs from that expressed in the nerve cord. Examination of the deduced translations of the alternative exons reveals the presence of three additional Mas-AT-like sequences that are flanked by basic amino acid residues. Therefore, the Mas-AT-like sequences present within the gene may be derived from a duplication of an ancestral Mas-AT-like sequence followed by divergence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179820     DOI: 10.1016/s0196-9781(00)00378-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Functional characterization of an allatotropin receptor expressed in the corpora allata of mosquitoes.

Authors:  Marcela Nouzova; Anne Brockhoff; Jaime G Mayoral; Marianne Goodwin; Wolfgang Meyerhof; Fernando G Noriega
Journal:  Peptides       Date:  2011-08-03       Impact factor: 3.750

2.  More than two decades of research on insect neuropeptide GPCRs: an overview.

Authors:  Jelle Caers; Heleen Verlinden; Sven Zels; Hans Peter Vandersmissen; Kristel Vuerinckx; Liliane Schoofs
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-30       Impact factor: 5.555

3.  Identification and expression of capa gene in the fire ant, Solenopsis invicta.

Authors:  Man-Yeon Choi; Rene Köhler; Robert K Vander Meer; Susanne Neupert; Reinhard Predel
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.